Emerald Advisers’s QuidelOrtho QDEL Stock Holding History

Emerald Advisers’s Portfolio QDEL Stock Details QDEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-300	Closed	-$40K	–	285
2021 Q4	$40K	Buy	+300	New	+$41.8K	﹤0.01%	263

Other funds holding QDEL

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Senvest Management New York $3.41B AUM 66.27% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Emerald Advisers's QDEL Position: Q1 2022 in Review

Emerald Advisers sold out of QuidelOrtho (QDEL) in Q1 2022, closing a stake of 300 shares — an estimated $40K sold.

Emerald Advisers first reported a position in QDEL in Q4 2021 and held it in 1 quarter. The position peaked at $40K in Q4 2021. 354 funds tracked by Wall St. Rank hold QDEL as of Q1 2022.

Emerald Advisers reported no remaining QuidelOrtho position as of Q1 2022 after selling out during the quarter.
Emerald Advisers sold 300 QuidelOrtho shares in Q1 2022, an estimated $40K.
Emerald Advisers first reported a position in QuidelOrtho in Q4 2021 and held it in 1 quarter.
Emerald Advisers's QuidelOrtho position peaked at $40K in Q4 2021.
354 funds tracked by Wall St. Rank held QuidelOrtho as of Q1 2022.

Based on Emerald Advisers's 13F filing for Q1 2022, filed 29 Apr 2022.